The US direct-to-consumer marketplace for autologous stem cell interventions

L Turner - Perspectives in biology and medicine, 2018 - muse.jhu.edu
Hundreds of businesses and clinics in the United States are engaged in direct-to-consumer
marketing of unproven and unlicensed stem cell–based interventions. This essay provides …

Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions

C Horner, E Tenenbaum, D Sipp… - NPJ Regenerative …, 2018 - nature.com
The sale of unproven stem cell interventions (SCIs) by commercial entities has proliferated
in highly developed countries, most notably in the USA. Yet, there have been few criminal …

Direct-to-consumer marketing of stem cell interventions by Canadian businesses

L Turner - Regenerative medicine, 2018 - Taylor & Francis
Aim: This study examines marketing claims of Canadian businesses engaged in direct-to-
consumer advertising of putative stem cell treatments. Methods: Internet searches were used …

Translating basic research into safe and effective cell-based treatments for respiratory diseases

L Ikonomou, DE Wagner, L Turner… - Annals of the American …, 2019 - atsjournals.org
Respiratory diseases, such as chronic obstructive pulmonary disease and pulmonary
fibrosis, result in severely impaired quality of life and impose significant burdens on …

The variability of judicial decisions in the stem cell industry in China

L Chen, J Gao, R Feng, Y Peng - Cell Stem Cell, 2023 - cell.com
As China's stem cell industry continues to develop, increasing disputes concerning stem cell-
based interventions have been brought before the courts. Nonetheless, there is variability in …

Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies

L Turner, JR Martinez, S Najjar… - Regenerative …, 2023 - Taylor & Francis
Aim: This study investigated whether US businesses engaged in direct-to-consumer online
marketing of purported stem cell therapies and stem cell-derived exosome products made …

Unproven Stem Cell-Based Interventions: Addressing Patients' Unmet Needs or Causing Patient Harms?

KRW Matthews - Medical Research Ethics: Challenges in the 21st …, 2023 - Springer
Unproven Stem Cell-Based Interventions: Addressing Patients’ Unmet Needs or Causing
Patient Harms? | SpringerLink Skip to main content Advertisement SpringerLink Account Menu …

[PDF][PDF] Ethical Issues in Tissue Engineering: A Systematic Review.

NSM Azharuddin, A Radzi… - Malaysian Journal of …, 2022 - medic.upm.edu.my
This study examines, classifies and discusses the ethical issues of tissue engineering
published in selected online databases from the year 2015 to 2020. In overview, the …

[PDF][PDF] Perspectivas e desafios regulatórios no uso de células-tronco em métodos alternativos ao uso de animais

CD da Silva Horinouchi, APR Abud… - Vigilância Sanitária em …, 2018 - redalyc.org
Introdução: Utilizar células-tronco para avaliações toxicológicas parece ser uma estratégia
promissora para permitir uma maior predição de efeitos em humanos. Entretanto, no Brasil …

[PDF][PDF] Comparative analysis of EU and US patent regulations on Human Embryonic Stem Cells

PJ Mikkola - digikogu.taltech.ee
Within the last few decades new emerging technologies have brought a rapid increase to
the development in the medical industry. As a result of these new technological …